MedPath

V-NAV Usability Study: End Users Trying the Vortant Indoor Navigation Tool

Not Applicable
Suspended
Conditions
Blindness and Low Vision
Registration Number
NCT05647694
Lead Sponsor
Vortant Technologies, LLC
Brief Summary

The study will begin with an explanatory/training session where individuals with low vision will learn to use the V-NAV (Vortant NAVigation tool) indoor navigation app, and will have the opportunity to try it for a few representative tasks. The main activity includes a take-home trial, an extended unstructured period to emulate the post-purchase experience of users, during which participants will have the opportunity to use the V-NAV in their everyday lives. Data will be collected from the users to measure the relative advantage of V-NAV compared to the user's current indoor navigation method.

Detailed Description

The introductory session, emphasizing real-world experiences, will involve a brief training session followed by simulated navigation experiences in a convenient location to the users. Participants will use V-NAV to record approximately 8 locations, then will be given instructions to find these locations again. The V-NAV prototype's logging software will measure distance walked and task time. Participants will complete a study-specific tool covering the relevant attributes of the V-NAV prototype, as well as a standardized tool, the NASA TLX (Task Load Index).

Subsequently, participants will complete a take-home trial, during which they will be encouraged to use the V-NAV features regularly to support their everyday community navigation activities. Participants will be contacted approximately weekly with a "check-in" to answer questions and resolve any emergent technical problems. At the conclusion of the trial, a product-specific tool and an appropriate standardized tool, the PIADS (Psychosocial Impact of Assistive Devices Scale) will be administered.

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • AFB "visually impaired" definition, acuity 20/70 or worse or field loss of 140 degrees
Exclusion Criteria
  • Any health condition that may affect safety of individual to participate
  • Any physical, mental, or behavioral impairment that would provide more than minimal risk or hindering ability to comprehend the purpose of the device or otherwise to be a potential user of the V-NAV hardware or app.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
V-NAV effectiveness4 weeks

A measurement of user impressions as to the value of the V-NAV navigation aid. Use of e.g., PIADS survey.

Secondary Outcome Measures
NameTimeMethod
V-NAV usability1 day

A measurement of how usable the V-NAV is. Use of e.g., NASA TLX survey.

Trial Locations

Locations (1)

Vortant Technologies

🇺🇸

Weaverville, North Carolina, United States

Vortant Technologies
🇺🇸Weaverville, North Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.